Skip to main content

The Structure of the Active Component of Hematoporphyrin Derivative

  • Chapter
Porphyrins in Tumor Phototherapy

Abstract

Photoradiation therapy (PRT) for local treatment of malignant tumors utilizing hematoporphyrin derivative (Hpd) as photosensitizing drug is undergoing clinical trials in several centers in the U. S. and abroad. This therapy is based on the localization and retention of Hpd in most tumors, as well as its photodynamic action which likely generates singlet oxygen at least as a first step. The only drug toxicity encountered to date in over 1500 patients receiving Hpd has been a generalized photosensitivity which requires patients to avoid bright light, especially sunlight, for 30 days or more. While this toxicity is avoidable it presents a drawback to utilizing PRT for early stage disease in ambulatory and active patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. C. Berenbaum, R. Bonnett and P. O. Scourides, In vivo biological activity of the components of hematoporphyrin derivative. Br. J. Cancer 45:571 (1982).

    Article  Google Scholar 

  2. P. S. Clezy, T. T. Hai, R. W. Henderson and L. Thuc, The chemistry of pyrrolic components XLV. Hematoporphyrin derivative diacetate as the main product of the reaction of hematoporphyrin with a mixture of active and sulfuric acid. Aust. J. Chem. 33:585 (1980).

    Article  Google Scholar 

  3. T. J. Dougherty, D. G. Boyle, K. R. Weishaupt, B. A. Henderson, W. R. Potter, D. A. Bellnier and K. E. Wityk, Photoradiation therapy — Clinical and drug advances, in: “Porphyrin Photosensitization,” D. Kessel and T. J. Dougherty, eds., Plenum Publishing Corp., New York (1983).

    Google Scholar 

  4. D. Kessel and T. Chow, Tumor-localizing components of the porphyrin preparation hematoporphyrin derivative. Can. Res. 43:1994 (1983).

    Google Scholar 

  5. G. Levy, Private communication (1983).

    Google Scholar 

  6. R. L. Lipson, The photodynamic and fluorescent properties of a particular hematoporphyrin derivative and its use in tumor detection. Masters Thesis, University of Minnesota (1960).

    Google Scholar 

  7. J. Moan and S. P. Sommer, Fluorescence and absorption properties of the components of hematoporphyrin derivative. Photobiochem. Photobiophys. 3:93 (1981).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Dougherty, T.J., Potter, W.R., Weishaupt, K.R. (1984). The Structure of the Active Component of Hematoporphyrin Derivative. In: Andreoni, A., Cubeddu, R. (eds) Porphyrins in Tumor Phototherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4721-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4721-7_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4723-1

  • Online ISBN: 978-1-4684-4721-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics